Nanoparticle drug delivery systems for cancer treatment (Record no. 71566)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02823cam a2200517Ki 4500 |
| 001 - CONTROL NUMBER | |
| control field | 9780429341250 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220531132400.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m d |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200222s2020 si o 000 0 eng d |
| 040 ## - Cataloging Source | |
| -- | OCoLC-P |
| -- | eng |
| -- | OCoLC-P |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781000681413 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1000681416 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429341250 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429341253 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781000680874 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1000680878 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781000681147 |
| -- | (electronic bk. : Mobipocket) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1000681149 |
| -- | (electronic bk. : Mobipocket) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1141511270 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC-P)1141511270 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC271.C5 |
| 072 #7 - | |
| -- | MED |
| -- | 009000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | MED |
| -- | 062000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | SCI |
| -- | 010000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | TBN |
| -- | bicssc |
| 082 04 - | |
| -- | 616.994061 |
| -- | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Nanoparticle drug delivery systems for cancer treatment |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Hala Gali-Muhtasib, Racha Chouaib. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Milton : |
| Name of publisher, distributor, etc. | Pan Stanford Publishing, |
| Date of publication, distribution, etc. | 2020. |
| 264 #1 - | |
| -- | Singapore : |
| -- | Jenny Stanford Publishing, |
| -- | 2019. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (342 p.) |
| 500 ## - GENERAL NOTE | |
| General note | Description based upon print version of record. |
| 520 ## - | |
| -- | In recent years, nanoparticles--bionanomaterials with specific physicochemical properties--have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs. This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research. |
| 588 ## - | |
| -- | OCLC-licensed vendor bibliographic record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer |
| General subdivision | Chemotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug delivery systems. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Nanomedicine. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Biotechnology |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Oncology |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | SCIENCE / Biotechnology |
| Source of heading or term | bisacsh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gali-Muhtasib, Hala, |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chouaib, Racha, |
| Relator term | editor. |
| 856 40 - | |
| -- | Taylor & Francis |
| -- | https://www.taylorfrancis.com/books/9780429341250 |
| 856 42 - | |
| -- | OCLC metadata license agreement |
| -- | http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
No items available.